Have received a live-virus vaccine within 30 days prior to planned treatment start.
Has received a live vaccine within 30 days of planned start of study therapy
Has received a live vaccine within 28 days of planned start of study therapy
Has received a live vaccine within 28 days of planned start of study therapy
Patients who have received a live vaccine within 30 days of the planned start of study therapy
Must not have received a live vaccine within 30 days of planned start of the study therapy
Has received a live vaccine within 30 days of planned start of study therapy
Has received a live vaccine within 30 days of planned start of study therapy
Has received a live vaccine within 30 days of planned start of study therapy
Has received a live vaccine within 30 days of planned start of study therapy
Has received a live vaccine within 30 days of planned start of study therapy
Received live vaccine within 30 days of planned start of study medication
Received a live vaccine within 30 days of planned start of study medication
Has received a live vaccine within 28 days of planned start of study therapy
Has received a live vaccine within 30 days of planned start of study therapy
Has received a live vaccine within 30 days of planned start of trial therapy.
Has received a live vaccine within 30 days of planned start of study therapy
Has received a live vaccine within 30 days of planned start of study therapy
Has received a live vaccine within 30 days of planned start of study therapy
Has received a live vaccine within 30 days of planned start of study therapy
Has received a live vaccine within 30 days of planned start of study therapy
Received a live virus vaccine within 30 days of planned start of therapy
Has received a live vaccine within 30 days of planned start of study therapy.
Received a live virus vaccine within 30 days of planned start of study treatment
Has received a live vaccine within 30 days of planned start of study therapy.
Has received a live vaccine within 30 days of planned start of study therapy
Has received a live vaccine within 30 days of planned start of study therapy
Has received a live vaccine within 30 days of planned start of study therapy
Has received a live vaccine within 30 days of planned start of study therapy
Has received a live vaccine within 30 days of planned start of study therapy
Received a live vaccine =< 30 days of planned start of study therapy
Received a live vaccine within 30 days of planned start of study medication
Has received a live vaccine within 30 days of planned start of study drug (Cycle 1, Day 1).
Has received a live vaccine within 30 days of planned start of study therapy.
Live vaccine within 30 days of planned start of study drug
Received a live virus vaccine within 30 days of planned study start
Has received a live virus vaccine within 30 days of planned start of trial treatment
Has received a live vaccine within 30 days of planned start of study drug (Cycle 1, Day 1)
Has received a live vaccine within 30 days of the planned first dose of the study
Receipt of a live vaccine within 30 days of planned start of study therapy.
Received a live vaccine within 30 days of planned start of study medication
Live vaccine within 30 days of planned start of study therapy
Received a live vaccine within 30 days of planned start of study medication
Received a live virus vaccine within 30 days of planned start of study treatment
Received a live virus vaccine within 30 days of planned start of trial treatment
Received live vaccine within 30 days of planned start of study therapy
Live vaccine within 30 days of planned start of study therapy
Has received live vaccine within 30 days of the planned start of study therapy
Received a live vaccine within 30 days of planned start of study treatment
Has received a live vaccine within 30 days of planned start of study therapy.
Has received a live vaccine within 30 days prior to the planned first dose of study therapy.
Patient who received a live vaccine within 30 days of planned start of study therapy
Patient who received a live vaccine within 30 days of planned start of study therapy
Has received a live vaccine within 28 days of planned start of study therapy
Received a live vaccine within 30 days of planned PD-1 start date.
Receipt of a live vaccine within 30 days of planned start of study drug.
Receipt of a live vaccine within 30 days of planned start of study therapy
